Glazer Capital LLC’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Glazer Capital LLC’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-339,122	Closed	-$13.6M	–	109
2016 Q3	$13.6M	Buy	+339,122	New	+$8.38M	2.66%	14

Glazer Capital LLC's CYNA Position: Q4 2016 in Review

Glazer Capital LLC sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 339,122 shares — an estimated $13.6M sold.

Glazer Capital LLC first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $13.6M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

Glazer Capital LLC reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
Glazer Capital LLC sold 339,122 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $13.6M.
Glazer Capital LLC first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
Glazer Capital LLC's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $13.6M in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Glazer Capital LLC's 13F filing for Q4 2016, filed 14 Feb 2017.